Navigation Links
Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
Date:1/23/2009

TARRYTOWN, N.Y., Jan. 23 /PRNewswire/ -- Aerolase Corporation, a leading manufacturer of next-generation portable lasers for aesthetic skin treatments, today announced that sales increased dramatically in 2008 over 2007. The company's unique product offerings in the aesthetic laser market helped to more than offset current economic conditions, according to Aerolase executives.

"December 2008 was a record sales month for Aerolase, and 2008 overall represented strong revenue growth with continued gains in Aerolase brand equity," said Dr. Pavel Efremkin, CEO. The company also reported that Q4 2008 revenues increased 119% compared with the corresponding period in 2007, and full-year 2008 revenues increased 76% vs. 2007.

"We are specifically pleased with increased popularity of our leading laser products -- LightPod Neo(TM) and LightPod Era(TM) which perform the full range of popular aesthetic laser skin treatments, including pain-free hair removal, facial skin rejuvenation, skin tightening, spider veins and other vascular lesion removal, scar reduction, treatment of pigmented lesions, acne clearance, tattoo reduction and many others."

In addition, the ASP (average selling price per laser) for LightPod lasers in 2008 increased 14% vs. 2007. "There is a clear and powerful trend of Primary Care Physicians (PCPs) actively adding medical aesthetic treatments to the scope of their regular medical practices," he said. "This trend is based on the increasing demand for rejuvenation from the aging population, who now actively seek these services from their trusted medical providers. The resulting new cash income is highly attractive for these PCPs whose economic circumstances continue to erode, thanks especially to declining reimbursement rates from medical insurers."

Sales to PCPs fueled the growth of Aerolase in 2008, with over half of its sales going into this market segment. The core segment of
'/>"/>

SOURCE Aerolase Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...0 The Michael J. Fox Fo...ounced $1.5 million in total awards to six researc...ifying therapies for Parkinson,s disease. The fund...g Discovery for Parkinson,s Disease program, made...YSE: ELN ), a neuroscience-based biotechnology c...
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)...Nov. 30 Novavax, Inc. (N...rollment in the Phase II clinical study of its tri...trains) VLP vaccine candidate in healthy adults 60...mized, double-blind, active-controlled study is co...y of two different doses (15 mcg and 60 mcg) of No...
(Date:11/30/2009)...v. 30 Cell Therapeutics,... that its new class of platinum-based anti-tumor c...ronger anti-tumor potency and activity compared to...ell as the ability to overcome cisplatin-resistanc...d in a paper titled "Novel Bis-platinum Complexes ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
...LMINGTON, Del., July 23 More than a third,of the ...inquire about the,company,s prescription savings p... or pharmacists, according to a year-long survey o...at 35 percent of the patients who called,AstraZene...ings programs,said they were referred by healthcar...
...livers Solid Financial Performance While Building ...e Corporation,(Nasdaq: GENZ ) today reported stro...along with significant progress in its commercial ...ent to approximately $1.171 billion from,$933.4 mi...was driven by,growth across all areas of the busin...
...CKENSACK, N.J., July 16 - Over the past two decade... an experimental treatment,to one that is a viable...gnancies and other life-threatening blood disorder...nd Marrow Stem Cell Transplantation Program,at The...nter are,responsible for many of the innovations a...
Other Biology Technology:AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 2AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 3Genzyme Reports Strong Second-Quarter Growth 2Genzyme Reports Strong Second-Quarter Growth 3Genzyme Reports Strong Second-Quarter Growth 4Genzyme Reports Strong Second-Quarter Growth 5Genzyme Reports Strong Second-Quarter Growth 6Genzyme Reports Strong Second-Quarter Growth 7Genzyme Reports Strong Second-Quarter Growth 8Genzyme Reports Strong Second-Quarter Growth 9Genzyme Reports Strong Second-Quarter Growth 10Genzyme Reports Strong Second-Quarter Growth 11Genzyme Reports Strong Second-Quarter Growth 12Genzyme Reports Strong Second-Quarter Growth 13Genzyme Reports Strong Second-Quarter Growth 14Genzyme Reports Strong Second-Quarter Growth 15Genzyme Reports Strong Second-Quarter Growth 16Genzyme Reports Strong Second-Quarter Growth 17Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 2Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 3Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 4
(Date:11/30/2009)...wer early bird registration rates and register onl...2010 at http://www.iofwco-ecceo10.org/ , WHAT...national Osteoporosis Foundation (IOF) and the Eur... Osteoporosis and Osteoarthritis (ESCEO). More tha...ected to attend. The exciting scientific programme...
(Date:11/30/2009)...ss and odorless radioactive gas that is produced b...duct of uranium decay and is found in trace amount...water as well as building materials, plants, anima...s expressed as the amount of radiation that would ...ter of air; thus the units are picocuries per lite...
(Date:11/26/2009)...vember 26, 2009) Whitehead researchers have devel...to pinpoint specific genes and proteins used by pa... In most human cell cultures genes are present in... from the mother. Gene inactivation by mutation is...activated, the second copy usually remains active ...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Knockouts in human cells point to pathogenic targets 2Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 1Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 2Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 3Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 4Brookstone Pharmaceuticals LLC becomes Acella Pharmaceuticals LLC 6284 1Child Food Allergies on the Rise in U S 61410 1Child Food Allergies on the Rise in U S 61410 2Child Food Allergies on the Rise in U S 61410 3
...e mid-1970s, Glenn Shaw of the Geophysical Institu...upon the notion of Arctic haze after collecting ae...any believed the Arctic to contain relatively pure...on. However, the concept was rocked once Shaws dat...hat hovered above the Arctic during winter and spr...
...oday (11 April) at the UK National Stem Cell Netwo... hope that bone stem cells may be harnessed to rep...symptoms of osteoarthritis. , Scientists at Cardi...lls within articular cartilage of adults, which al...full stem cells, has the ability to derive into ch...
...f events, two comprehensive, collaborative project...from the American Museum of Natural History will g... this week. For the paper in Science, herpetologis...thy and colleagues analyzed thousands of species, ... to determine a conservation plan for a tropical h...
Other Biology News:Atmospheric scientists gear up for collaborative airborne campaigns 2Stem cells offer cartilage repair hope for arthritis sufferers 2AMNH scientists grace Science & Nature covers 2AMNH scientists grace Science & Nature covers 3
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
... Idaho Technologys R.A.P.I.D. System (Ruggedized A...d, real-time, PCR thermocycler designed for field ...ironments. In addition to its ruggedness, it is de...e LightCycler instrument. By taking advantage of t...
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Biology Products: